|
|
Post by olderteampt on May 28, 2020 13:41:45 GMT -5
How many molecules in AMGN's pipeline would fit well with MNKD's inhaler? Just think how that would benefit AMGN in the long run. That would send a message to AMGN's competitors like no other.
|
|
|
|
Post by buyitonsale on May 28, 2020 16:25:37 GMT -5
Feel free to send a message to AMGN IR... so far the only company interested in TS technology is United Therapeutics.
|
|
|
|
Post by boytroy88 on May 29, 2020 15:22:09 GMT -5
Feel free to send a message to AMGN IR... so far the only company interested in TS technology is United Therapeutics. Be interesting to see if MNKD will start getting more partnerships once UT starts selling... |
|
|
|
Post by buyitonsale on May 29, 2020 15:32:35 GMT -5
Yes, and hopefully when our other "silent partner" RLS finally makes use of their TS license...
|
|
|
|
Post by peppy on May 29, 2020 17:32:02 GMT -5
How many molecules in AMGN's pipeline would fit well with MNKD's inhaler? Just think how that would benefit AMGN in the long run. That would send a message to AMGN's competitors like no other. I have looked. Not that many. Regeneron has more medicines for the dreamboat. |
|
|
|
Post by longliner on May 29, 2020 18:28:10 GMT -5
|
|
|
|
Post by longliner on May 29, 2020 18:29:51 GMT -5
How many molecules in AMGN's pipeline would fit well with MNKD's inhaler? Just think how that would benefit AMGN in the long run. That would send a message to AMGN's competitors like no other. I have looked. Not that many. Regeneron has more medicines for the dreamboat. Back to the hated Sanofi!  Of course, time wounds all heels....or something like that.  |
|
|
|
Post by peppy on May 29, 2020 22:00:36 GMT -5
I have looked. Not that many. Regeneron has more medicines for the dreamboat. Back to the hated Sanofi! Of course, time wounds all heels....or something like that. hated Sanofi is divesting from Regeneron. they want 13 billion for their share. Sanofi saying they want the money for cancer. |
|
|
|
Post by cretin11 on May 30, 2020 6:58:27 GMT -5
It would cost Amgen, Pfizer, Sanofi or anybody else less than a billion $ to simply acquire MNKD, so if they saw multiple drug value potential in Technosphere wouldn’t that be the play they’d make?
|
|
|
|
Post by akemp3000 on May 30, 2020 7:43:30 GMT -5
Less than a billion to acquire MNKD?? A theoretical purchase of MNKD based on current market cap is not the way a buyout would work. Would enjoy seeing that offer just to put the company in play and see what followed. That would get interesting indeed.
|
|
|
|
Post by cretin11 on May 30, 2020 7:46:09 GMT -5
Would definitely love to see it too, just for the excitement of it. But a 3X multiple of current value, yes I think that amount would likely be enough to get it done.
|
|
|
|
Post by veritasfiliatemporis on May 30, 2020 7:56:39 GMT -5
It would cost Amgen, Pfizer, Sanofi or anybody else less than a billion $ to simply acquire MNKD, so if they saw multiple drug value potential in Technosphere wouldn’t that be the play they’d make? They can't... |
|
|
|
Post by nylefty on May 30, 2020 10:34:53 GMT -5
It would cost Amgen, Pfizer, Sanofi or anybody else less than a billion $ to simply acquire MNKD, so if they saw multiple drug value potential in Technosphere wouldn’t that be the play they’d make? They can't... Please elaborate. |
|
|
|
Post by babaoriley on May 30, 2020 11:26:14 GMT -5
We’d be gone so fast for a billion it would make the speed of light seem slow! |
|
|
|
Post by veritasfiliatemporis on May 30, 2020 12:07:27 GMT -5
It has to be hostile... They can't, check the last annual meeting numbers... |
|
Of course, time wounds all heels....or something like that. 
